Effects of antithrombin III (AT III) and Trp49-modified AT III on plasma level of 6-keto-PGF1 alpha in rats.

No abstract is available for this paper.

• Publication year

  1995

• Venue

  Thrombosis Research

• Publication date

  1995-11-01

• Fields of study

  Medicine, Chemistry

• Identifiers
  DOI 10.1016/0049-3848(95)00168-QPMID 8578546
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Hematologic disorders and ischemic stroke.

  1995cited by this paper
• Homozygous Antithrombin Deficiency: Report of Two New Cases (99 Leu to Phe) Associated with Arterial and Venous Thrombosis

  1994cited by this paper
• Reduction of Mortality with Antithrombin III in Septicemic Rats: A Study of Klebsiella pneumoniae Induced Sepsis

  1993cited by this paper
• Antithrombin III Nagasaki (Ser116-Pro): a heterozygous variant with defective heparin binding associated with thrombosis.

  1993cited by this paper
• Heparin and Related Polysaccharides

  1992cited by this paper
• Heparin protein interactions.

  1992cited by this paper
• Heparin-like glycosaminoglycan is a receptor for antithrombin III-dependent but not for thrombin-dependent prostacyclin production in human endothelial cells.

  1990cited by this paper
• Hematologic disorders and ischemic stroke. A selective review.

  1990cited by this paper
• Homozygous Variant of Antithrombin III that Lacks Affinity for Heparin, AT III Kumamoto

  1989cited by this paper
• Antithrombin III stimulates prostacyclin production by cultured aortic endothelial cells.

  1989cited by this paper
• Serum prostacyclin stabilizing factor is identical to apolipoprotein A-I (Apo A-I). A novel function of Apo A-I.

  1988cited by this paper
• Antithrombin III Alger: A New Homozygous AT III Variant

  1986cited by this paper
• Homozygous Variant of Antithrombin III : AT III Fontainebleau

  1986cited by this paper
• The role of tryptophan residues in heparin-antithrombin interactions.

  1984cited by this paper
• In vivo behavior of radioiodinated rabbit antithrombin III. Demonstration of a noncirculating vascular compartment.

  1984cited by this paper
• Antithrombin III Toyama: a hereditary abnormal antithrombin III of a patient with recurrent thrombophlebitis.

  1983cited by this paper
• The role of prostacyclin in vascular tissue.

  1979cited by this paper

• The Effects of Mammary Gland ATIII Overexpression on the General Health of Dairy Goats and Their Anti-Inflammatory Response to LPS Stimulation

  2023cites this paper
• The relationship between antithrombin administration and inflammation during veno-venous ECMO

  2022cites this paper
• Clinical controversies in anticoagulation monitoring and antithrombin supplementation for ECMO

  2020cites this paper
• Antithrombin supplementation during extracorporeal membrane oxygenation: study protocol for a pilot randomized clinical trial

  2018cites this paper
• HS3ST1 genotype regulates antithrombin's inflammomodulatory tone and associates with atherosclerosis.

  2017cites this paper
• SerpinC1/Antithrombin III in kidney-related diseases

  2017cites this paper
• Evaluation d'un variant d'antithrombine dans différentes indications thérapeutiques

  2016influential citation
• Antithrombin: anti-inflammatory properties and clinical applications

  2015cites this paper
• Anticoagulant heparan sulfate to not clot--or not?

  2010cites this paper
• The role of haptoglobin in phagocyte-mediated killing of Staphylococcus aureus

  2010cites this paper
• Inhibition of Thrombin in Cardiac Surgery : experiments in a porcine model

  2009cites this paper
• Antithrombin* Reduces Ischemic Volume, Ameliorates Neurologic Deficits, and Prolongs Animal Survival in Both Transient and Permanent Focal Ischemia

  2007cites this paper
• Antithrombin reduces pulmonary hypertension during reperfusion after cardiopulmonary bypass in a pig

  2007cites this paper
• Antithrombin reduces endotoxin-induced hypotension by enhancing pulmonary sensory neuron activation in rats

  2006cites this paper
• Antithrombin reduces reperfusion-induced liver injury in mice by enhancing sensory neuron activation

  2006cites this paper
• Importance of Airway Management in Burn and Smoke Inhalation-induced Acute Lung Injury

  2006cites this paper
• Antithrombin III pretreatment reduces neutrophil recruitment into the lung in a rat model of abdominal sepsis

  2005cites this paper
• Antithrombin III pretreatment reduces neutrophil recruitment into the lung and skeletal muscle tissues in the rat model of bilateral lower limb ischemia and reperfusion: a pilot study *

  2005cites this paper
• Antithrombin III in Healthy Dogs and in Dogs Suffering from Babesiosis

  2005cites this paper
• Antithrombin III in sepsis: does it really work?

  2005cites this paper
• Effects of Antithrombin III on Myeloperoxidase Activity, Superoxide Dismutase Activity, and Malondialdehyde Levels and Histopathological Findings after Spinal Cord Injury in the Rat

  2005cites this paper
• Antithrombin reduces ischemia/reperfusion-induced liver injury in rats by activation of cyclooxygenase-1

  2004cites this paper
• Contribution of capsaicin-sensitive sensory neurons to antithrombin-induced reduction of ischemia/reperfusion-induced liver injury in rats

  2004cites this paper
• Antithrombin reduces ischemia/reperfusion-induced renal injury in rats by inhibiting leukocyte activation through promotion of prostacyclin production.

  2003cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2003cites this paper
• Recombinant antithrombin attenuates pulmonary inflammation following smoke inhalation and pneumonia in sheep

  2003cites this paper
• Rebuttal to: Effect of heparin on TAFI‐dependent inhibition of fibrinolysis

  2003cites this paper
• Rebuttal to: Effect of heparin on TAFI‐dependent inhibition of fibrinolysis

  2003cites this paper
• Influence of antithrombin on ischemia/reperfusion injury in the isolated blood-free perfused rat heart.

  2002cites this paper
• Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.

  2002cites this paper
• Interference with the Coagulation System

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Antithrombin prevents endotoxin-induced hypotension by inhibiting the induction of nitric oxide synthase in rats.

  2002cites this paper
• Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Aspirin resistance is not a common biochemical phenotype explained by unblocked cyclooxygenase-1 activity.

  2002cites this paper
• High-Dose Antithrombin Therapy for Sepsis: Mechanisms of Action

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Syndecan-4 mediates antithrombin-induced chemotaxis of human peripheral blood lymphocytes and monocytes.

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• The antithrombin III-saving effect of reduced systemic heparinization and heparin-coated circuits.

  2002cites this paper
• Successful treatment of bone marrow transplant--associated thrombotic microangiopathy with antithrombin-III.

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Outpatient treatment of pulmonary embolism is feasible and safe in a substantial proportion of patients 1

  2002cites this paper
• Antithrombin (AT) - Wirkung: Experimentelle und klinische Ergebnisse

  2001cites this paper
• Syndecan-4 as antithrombin receptor of human neutrophils.

  2001cites this paper
• [Actions of Antithrombin (AT): experimental and clinical results].

  2001cites this paper
• Antithrombin III reduces renal ischemia-reperfusion injury in rats.

  2001cites this paper
• Acquired antithrombin deficiency in sepsis

  2001cites this paper
• High Prevalence of Factor V Leiden Mutation among Healthy Individuals and Patients with Deep Venous Thrombosis in Lebanon:

  2001cites this paper
• Antithrombin Does not directly Promote the Endothelial Production of Prostacyclin in Cultured Endothelial Cells

  2001cites this paper
• Recombinant antithrombin: production and role in cardiovascular disorder.

  2001cites this paper
• Recombinant Antithrombin: Production and Role in Cardiovascular Disorder

  2001cites this paper
• Antithrombin III and Tissue Factor Pathway Inhibitor: Two Physiologic Protease Inhibitors of the Coagulation System

  2000cites this paper
• Influence of heparin and hirudin on endothelial binding of antithrombin in experimental thrombinemia

  2000cites this paper
• Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach.

  2000cites this paper
• Antithrombin prevents stress-induced gastric mucosal injury by increasing the gastric prostacyclin level in rats.

  1999cites this paper
• The Inflammatory Effect of Coagulation and the Antiinflammatory Effect of Anticoagulation in Sepsis and Shock

  1999cites this paper
• Antithrombin III Effects on the Production of Vasoactive Substances in Endotoxemic Rats

  1999cites this paper
• New Potential Therapeutic Modalities: Antithrombin III

  1999cites this paper
• Antithrombin III prevents 60 min warm intestinal ischemia reperfusion injury in rats

  1999cites this paper
• Influence of antithrombin III on coagulation and inflammation in porcine septic shock.

  1999cites this paper
• Antithrombin reduces ischemia/reperfusion injury of rat liver by increasing the hepatic level of prostacyclin.

  1999cites this paper
• The Role of Leukocytes in Disseminated Intravascular Coagulation Associated with Sepsis

  1999cites this paper
• Antithrombin und Kombination mit Antikoagulanzien

  1998cites this paper
• Effects of various doses of antithrombin III on endotoxin-induced endothelial cell injury and coagulation abnormalities in rats.

  1998cites this paper
• The Anti-Inflammatory Properties of Antithrombin III: New Therapeutic Implications

  1998cites this paper
• The effect of antithrombin on the systemic inflammatory response in disseminated intravascular coagulation.

  1998cites this paper
• Antithrombin prevents endotoxin-induced pulmonary vascular injury by inhibiting leukocyte activation.

  1998cites this paper
• The Management of Sepsis: A Practical Review

  1998cites this paper
• Antithrombin III in Animal Models of Sepsis and Organ Failure

  1998cites this paper
• rhs-TM prevents ET-induced increase in pulmonary vascular permeability through protein C activation.

  1997cites this paper
• Antithrombin III (AT III) Prevents LPS-Induced Pulmonary Vascular Injury: Novel Biological Activity of AT III

  1997cites this paper
• Antithrombin III modulator of coagulation and inflammatory reaction.

  1997cites this paper